Search Results - Cherng, Deborah Weng

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial

    Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial by Kahn, J O, Cherng, D W, Mayer, K, Murray, H, Lagakos, S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

    Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk by Tebas, Pablo, Henry, William Keith, Matining, Roy, Weng-Cherng, Deborah, Schmitz, John, Valdez, Hernan, Jahed, Nasreen, Myers, Laurie, Powderly, William G, Katzenstein, David

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Safety, Tolerability, and Pharmacokinetic Effects of Thalidomide in Patients Infected with Human Immunodeficiency Virus: AIDS Clinical Trials Group 267

    Safety, Tolerability, and Pharmacokinetic Effects of Thalidomide in Patients Infected with Human Immunodeficiency Virus: AIDS Clinical Trials Group 267 by Wohl, David A., Aweeka, Francesca T., Schmitz, John, Pomerantz, Roger, Cherng, Deborah Weng, Spritzler, John, Fox, Lawrence, Simpson, David, Bell, Dawn, Holohan, M.K., Thomas, Steven, Robinson, Wayne, Kaplan, Gilla, Teppler, Hedy

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of HIV-1 Immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 106/L CD4 cell counts : A randomized controlled trial

    Evaluation of HIV-1 Immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 106/L CD4 cell counts : A randomized controlled trial by KAHN, James O, CHERNG, Deborah Weng, MAYER, Kenneth, MURRAY, Henry, LAGAKOS, Stephen

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 106/L CD4 Cell Counts: A Randomized Controlled Trial

    Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 106/L CD4 Cell Counts: A Randomized Controlled Trial by Kahn, James O, Cherng, Deborah Weng, Mayer, Kenneth, Murray, Henry, Lagakos, Stephen, for the 806 Investigator Team

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: